Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3616

A new dawn for psychedelics? Compass could be the first to find out

$
0
0
The summer of 2024 was a dark time for psychedelics. The sector was reeling after Lykos Therapeutics failed to secure FDA approval for its MDMA-assisted therapy for post-traumatic stress disorder. Lykos’ success ...

Viewing all articles
Browse latest Browse all 3616

Trending Articles